Cargando…
Epigenetics of methylation modifications in diabetic cardiomyopathy
Type 2 diabetes is one of the most common metabolic diseases with complications including diabetic cardiomyopathy and atherosclerotic cardiovascular disease. Recently, a growing body of research has revealed that the complex interplay between epigenetic changes and the environmental factors may sign...
Autores principales: | Hao, Jing, Liu, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050754/ https://www.ncbi.nlm.nih.gov/pubmed/37008904 http://dx.doi.org/10.3389/fendo.2023.1119765 |
Ejemplares similares
-
Epigenetic modification in diabetic kidney disease
por: Liu, Zhe, et al.
Publicado: (2023) -
Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
por: Khullar, Madhu, et al.
Publicado: (2017) -
NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2021) -
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022) -
Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
por: Catalano, Maria Graziella, et al.
Publicado: (2012)